FOI2026/00818 - Assessment/approval/and/or post-authorisation monitoring of Librela and Solensia
Published 12 August 2026
© Crown copyright 2026
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/vmd-foieir-requests-may-2026/foi202600818-assessmentapprovalandor-post-authorisation-monitoring-of-librela-and-solensia
1. Your request
Please provide the following information in relation to the assessment, approval, and/or post-authorisation monitoring of Librela and Solensia:
1. The number of current or recent staff within the Veterinary Medicines Directorate who have previously been employed by Zoetis and who have been involved in any capacity in:
a) advisory roles prior to approval of Librela and Solensia
b) the initial assessment or approval of these products; and/or
c) post-marketing surveillance, including pharmacovigilance activities.
-
For any such staff identified in aggregate form above, please confirm:
a) whether they were permitted to contribute to scientific advice, evaluation, or regulatory decision-making relating to these products;
b) whether any restrictions, recusals, or mitigations were applied due to prior employment;
c) whether any internal review or management of potential conflicts of interest was undertaken. -
Please provide copies of, or references to, the policies, procedures, or guidance documents governing the management of conflicts of interest arising from prior employment in the pharmaceutical or veterinary medicines industry, specifically as applied to staff involved in the regulation of monoclonal antibody veterinary medicines.
-
Please confirm whether the VMD holds any recorded information (in anonymised or aggregated form) indicating whether staff with prior employment at Zoetis were excluded from, or permitted to participate in, decision-making processes relating to these products.
2. Our reply
We have previously responded to a similar request, FOI2026/00266 which will be published on our disclosure log in due course. For your convenience, a copy of that response is attached.